IndraLab

Statements


| 6

reach
"On the other hand, stavudine (D4T) downregulates the NLRP3 inflammasome and stimulates autophagy-mediated Abeta-clearing in a THP-1-derived macrophages."

reach
"For example, benzylisothiocyanate (126), stavudine (127), and artemisinin (128) all have shown therapeutic effects on AD mice by inhibiting NLRP3 activation.5.3 Regulation of phenotypic variations in microglia."

reach
"A great achievement was reached when a potent diarylsulfonylurea compound MCC950 (also termed as CRID3, CP-456773), endowed with NLRP3 selectivity, showed therapeutic improvement in several preclinical models such as experimental autoimmune encephalomyelitis, such as AD and PD [229-232], nevertheless it failed in clinical trials because of off-target toxicity.In the search for new inhibitors Stavudine (d4T), acting as an inhibitor of nucleoside reverse transcriptase, has been published recently to downregulate NLRP3 activation in AD [233]."

reach
"Stavudine "Interferes" via alpha-7nAChR to Inhibit NLRP3 in (LPS+Amyloid-Beta) Stimulated PBMC of AD Patients."

reach
"MCC950 and stavudine reduce NLRP3 activation and may contribute to the blockade of the IL-1β pathway [ 94 , 95 ]."

reach
"Stavudine Reduces NLRP3 Inflammasome Activation and Modulates Amyloid-beta Autophagy."